Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:00 AM ET 8-K
M&A Deal Launch Two Acquisition Corp. LPBB

Launch Two Acquisition M&A Deal with NuCube Energy, Inc.

Launch Two Acquisition Corp. entered into an amendment to its existing business combination agreement with NuCube Energy, Inc., extending the deal's outside closing date to January 7, 2027. The amendment also permits NuCube to conduct interim financing through the issuance of Series A-4 Preferred Stock and increases the post-closing employee incentive plan share reserve to 12.5%.

Counterparty
NuCube Energy, Inc.
7:32 AM ET 8-K
Divestiture Prudential Financial Inc PRU

Prudential Financial Divestiture to CNP Assurances Group for $4.03B

Prudential Financial has entered into definitive agreements to sell its equity interests in Prudential of Brazil and Prudential of Mexico to CNP Assurances for approximately $4.025 billion in cash. The transaction is part of Prudential's strategy to exit emerging markets and refocus capital on its core growth opportunities in the U.S., Japan, and select European markets.

Value
$4.03B
Counterparty
CNP Assurances Group
7:26 AM ET 8-K
M&A Deal Maximus, Inc. MMS

Maximus Signs $660M M&A Deal with Agile Defense, LLC

Maximus, Inc. has entered into a definitive agreement to acquire Agile Defense, LLC for $660 million in cash, plus up to $50 million in contingent earnout payments. The acquisition aims to expand Maximus' presence in the defense and national security markets by adding specialized cybersecurity, AI, and digital transformation capabilities. The deal is expected to close in the first quarter of fiscal year 2027, subject to regulatory approvals.

Value
$660M
Counterparty
Agile Defense, LLC
7:06 AM ET 8-K
Partnership Hertz Global Holdings, Inc HTZ

Hertz Global Holdings Partnership with Cohen Private Ventures Worth $80.9M

Hertz entered into a joint venture arrangement for its Oro Mobility business, with a consortium of investors purchasing a 50% voting interest and 15.86% economic interest in the JV entity for $80.89 million. Hertz will retain majority economic ownership and serve as a fleet and corporate services partner to Oro, which operates approximately 45,000 vehicles across U.S. mobility markets. Concurrently, Hertz repurchased $51.1 million of its 2029 exchangeable notes from the investors at a 60% discount to par.

Value
$80.9M
Counterparty
Cohen Private Ventures, Certares Opportunities LLC, and Knighthead Capital Management, LLC
7:01 AM ET 8-K
M&A Deal Iridium Communications Inc. IRDM

Iridium Communications M&A Deal with Rocket Lab Corporation

Iridium provided a status update on its pending acquisition by Rocket Lab, noting that stockholders approved the transaction on September 24, 2026, with 99.6% of votes cast in favor. The deal is expected to close by mid-2027, following the company's recent completion of its acquisition of Aireon.

Counterparty
Rocket Lab Corporation

“Last month’s stockholder approval for Rocket Lab’s acquisition of Iridium was an important milestone in creating a next generation space powerhouse.”

Matt Desch, CEO, Iridium

“The combination of these two leading space companies will unlock new innovation in the space industry and accelerate our growth in critical space-based missions.”

Matt Desch, CEO, Iridium
7:01 AM ET 8-K
Clinical Trial Data Odyssey Therapeutics, Inc. ODTX

Odyssey Therapeutics Clinical Trial Data

Odyssey Therapeutics announced positive Phase 2a results for its oral RIPK2 inhibitor, OD-001, in patients with moderate-to-severe ulcerative colitis. The trial met its primary endpoint with a 27% clinical remission rate at the 20 mg BID dose at Week 12, showing significant correlation between clinical efficacy and inflammatory biomarkers.

6:35 AM ET 8-K
Clinical Trial Data Quoin Pharmaceuticals Ltd. QNRX

Quoin Pharmaceuticals Clinical Trial Data

Quoin Pharmaceuticals announced the publication of a peer-reviewed case report detailing 21 months of compassionate use treatment with QRX003 in a pediatric Netherton Syndrome patient, showing an improvement from severe to clear skin. The company also reaffirmed that its ongoing Phase 2/3 study of QRX003 expects to complete recruitment by the end of 2026 with topline data anticipated in Q2 2027.

Term
21 months
6:06 AM ET 8-K
Clinical Trial Data Rapport Therapeutics, Inc. RAPP

Rapport Therapeutics Clinical Trial Data

Rapport Therapeutics announced positive topline results from its Phase 2 trial of RAP-219 for the treatment of bipolar mania, meeting the primary endpoint with a statistically significant 3.1-point placebo-adjusted improvement in the YMRS total score. The drug was well-tolerated with no serious adverse events, establishing clinical proof-of-concept for its novel TARP g8-selective mechanism. The company plans to progress RAP-219 into Phase 3 trials for bipolar mania in the second half of 2027.

6:03 AM ET 8-K
Capital Raise BioAtla, Inc. BCAB

BioAtla Capital Raise

BioAtla, Inc. entered into a Standby Equity Purchase Agreement (SEPA) with Yorkville, establishing a facility to sell up to $40.0 million of common stock at the company's option. Shares will be sold at 97% of the lowest daily VWAP over a three-day pricing period following an advance notice. As consideration, the company agreed to pay a $500,000 commitment fee, partially settled through the issuance of warrants for 182,110 shares.

Counterparty
YA II PN, Ltd.
Term
36 months
6:02 AM ET 8-K
M&A Deal Silgan Holdings Inc SLGN

Silgan Holdings Signs $1.02B M&A Deal with Trivium Packaging B.V.

Silgan Holdings entered into a definitive agreement to form a partnership with AIP, LLC (A-VL Investor) to combine Silgan's Metal Containers and Closures Business with Trivium Packaging B.V. Silgan will contribute its business for a 60% stake in the new entity (MetalCo) and a $2.263 billion cash distribution, while A-VL Investor will contribute $1.025 billion for a 40% stake.

Value
$1.02B
Counterparty
Trivium Packaging B.V.
5:25 PM ET 8-K
M&A Deal Treasure Global Inc TGL

Treasure Global M&A Deal with Platinum Recognition Sdn. Bhd.

Treasure Global Inc (TGL), through its subsidiary Tadaa Capital Sdn. Bhd., entered into a definitive agreement to acquire 100% of Platinum Recognition Sdn. Bhd. (PRSB), a Malaysian budget hotel operator. The purchase price is RM2,400,000, consisting of a 10% cash deposit and 90% payable through an escrow realization scheme involving the issuance of TGL common stock.

Counterparty
Platinum Recognition Sdn. Bhd.
5:25 PM ET 8-K
M&A Deal Tessera Defense & Homeland Security Inc. HLSQ

Tessera Defense & Homeland Security M&A Deal with Mandragola Ltd.

Tessera Defense and Homeland Security Inc. issued 6,529,494 restricted shares of common stock to Mandragola Ltd. following the cashless exercise of warrants. These warrants were originally issued in April 2026 as part of the consideration for Tessera's acquisition of a 60% interest in Dr. Frucht Systems Ltd. (DFSL).

Counterparty
Mandragola Ltd.
5:20 PM ET 8-K
Capital Raise Venu Holding Corp VENU

Venu Holding Capital Raise of $5.01M

Venu Holding Corp completed the second and final tranche of a $10 million equity investment from Aramark, raising $5.01 million through the sale of 334 shares of Series B Preferred Stock. Additionally, the company announced that William Hodgson has stepped down as President, with his responsibilities being assumed by the existing management team.

Value
$5.01M
Counterparty
Aramark Sports and Entertainment Services, LLC
5:18 PM ET 8-K
M&A Deal Tradeweb Markets Inc. TW

Tradeweb Markets Signs $1.97B M&A Deal with Trumid Holdings, LLC

Tradeweb Markets Inc. has entered into a definitive agreement to acquire electronic credit trading marketplace Trumid for approximately $1.97 billion. The deal combines Tradeweb's multi-asset platform with Trumid's innovative credit protocols to expand capabilities into the full bond lifecycle, including new issue origination and secondary trading.

Value
$1.97B
Counterparty
Trumid Holdings, LLC

“This acquisition represents an important step forward in our ambition to make credit markets more efficient and provide clients with smarter ways to access liquidity. We believe U.S. credit represents a significant long-term growth opportunity, particularly as the market continues to embrace electronic execution and as clients seek increasingly sophisticated solutions to navigate liquidity and achieve better outcomes.”

Billy Hult, CEO of Tradeweb

“We look forward to incorporating our innovative protocols, agile technology, and collaborative client-centric approach to product development into Tradeweb’s global footprint and client network. Our teams share dual passions for technology and client experience.”

Mike Sobel, Co-CEO and President of Trumid
5:16 PM ET 8-K
M&A Deal LXP Industrial Trust LXP

LXP Industrial Trust M&A Deal with Leopard REIT LLC

LXP Industrial Trust provided a status update on its pending merger with Leopard REIT LLC, specifically addressing shareholder litigation and demand letters alleging disclosure deficiencies in the proxy statement. To avoid potential delays to the merger and minimize litigation costs, the company has voluntarily supplemented its definitive proxy statement ahead of the special meeting of shareholders scheduled for October 26, 2026.

Counterparty
Leopard REIT LLC
5:00 PM ET 8-K
Nasdaq/NYSE Compliance Notice Stardust Power Inc. SDST

Stardust Power Nasdaq/NYSE Compliance Notice

Stardust Power Inc. received a Staff Delisting Determination from Nasdaq on October 15, 2026, after its common stock closed at $0.10 or less for ten consecutive trading days. Nasdaq intends to suspend trading and delist the company's securities on October 23, 2026, though the company may appeal the decision to the Nasdaq Hearings Panel.

Counterparty
Nasdaq
4:59 PM ET 8-K
Capital Raise Tcgx Acquisition Corp. II TCXB

Tcgx Acquisition Corp. II Capital Raise of $104M

TCGX Acquisition Corp. II consummated its initial public offering (IPO) of 10,000,000 Class A ordinary shares at $10.00 per share, raising $100 million in gross proceeds. Simultaneously, the company raised an additional $4.5 million through a private placement of 450,000 shares to its sponsor, TCGX Sponsor II, LLC.

Value
$104M
Counterparty
Guggenheim Securities, LLC
4:55 PM ET 8-K
Partnership 3M Co MMM

3M Partnership with Amazon.com, Inc.

3M Company has entered into an expanded strategic commercial relationship with Amazon for optical connectivity and other Data Center products. As part of the deal, 3M issued a warrant to Amazon to purchase up to 3.16 million shares at $164.89 per share, with vesting tied to Amazon making up to $6 billion in cumulative payments for 3M products.

Counterparty
Amazon.com, Inc.
Term
7 years
4:51 PM ET 8-K
M&A Deal AES Corp AES

AES M&A Deal with Horizon Parent, L.P.

The AES Corporation received unconditional merger approval from the European Commission and a favorable declaratory ruling from the New York Public Service Commission regarding its pending acquisition by Horizon Parent, L.P. The transaction, originally announced in March 2026, will result in AES being jointly owned by Global Infrastructure Management, LLC and EQT Infrastructure VI. The deal remains subject to additional regulatory approvals and customary closing conditions.

Counterparty
Horizon Parent, L.P.
4:51 PM ET 8-K
Capital Raise VenHub Global, Inc. VHUB

VenHub Global Capital Raise

VenHub Global announced that its existing Equity Line of Credit (ELOC) has been assigned from Euphoria Capital to Tunim Stone Capital, LLC. Under the Assignment and Assumption Agreement, Tunim Stone Capital assumes all rights and obligations of the ELOC, while Euphoria Capital retains 500,000 commitment shares and associated registration rights.

Counterparty
Tunim Stone Capital, LLC.
4:50 PM ET 8-K
M&A Deal Vivos Therapeutics, Inc. VVOS

Vivos Therapeutics Signs $12M M&A Deal with SOD Sciences, Inc.

Vivos Therapeutics completed the acquisition of an 11% equity stake in SOD Sciences and a 50% co-ownership interest in SOD's pseudohypoxia early-warning test. The transaction was valued at $12 million, paid via the issuance of 12,000 shares of Series C Convertible Preferred Stock, and is expected to add over $10 million to Vivos' stockholders' equity.

Value
$12M
Counterparty
SOD Sciences, Inc.

“Today Vivos became more than a healthcare company just treating sleep apnea. We expect this transaction to add more than $10 million to our stockholders’ equity, and we now own half of a test designed to identify patients whose sleep apnea may be contributing to chronic disease.”

R. Kirk Huntsman, Chairman and Chief Executive Officer of Vivos
4:42 PM ET 8-K
Divestiture Service Properties Trust SVC

Service Properties Trust Divestiture for $19M

Service Properties Trust (SVC) completed the sale of three hotels for an aggregate sales price of $19.0 million on October 15, 2026. The transaction was executed pursuant to a previously entered purchase and sale agreement and was reported as a significant disposition of assets.

Value
$19M
4:40 PM ET 8-K
Capital Raise Eva Live Inc GOAI

Eva Live Capital Raise

Eva Live Inc. filed a prospectus supplement to facilitate an existing equity purchase agreement with Hudson Global Ventures, LLC. The agreement allows the company to sell up to 5,000,000 shares of common stock for an aggregate price of up to $10 million. Additionally, the company issued a warrant to the investor for 275,000 shares at an exercise price of $0.01 per share.

Counterparty
Hudson Global Ventures, LLC
4:31 PM ET 8-K
Capital Raise Curis Inc CRIS

Curis Capital Raise of $8.5M

Curis, Inc. entered into a securities purchase agreement to raise approximately $8.5 million through the sale of 16,666,680 shares of common stock (or pre-funded warrants) and accompanying common warrants at a combined price of $0.51 per share. The company intends to use the proceeds to fund research and development activities, specifically to support operations through its initial Chronic Lymphocytic Leukemia (CLL) data readout expected in December 2026.

Value
$8.5M
4:24 PM ET 8-K
Divestiture Medtronic plc MDT

Medtronic Divestiture

Medtronic plc has completed the separation of its diabetes business, MiniMed Group, Inc., into an independent publicly traded company via a tax-free exchange offer. Medtronic exchanged its remaining 252,813,348 shares of MiniMed common stock for outstanding Medtronic ordinary shares in an offer that was 5.4x oversubscribed.

4:23 PM ET 8-K
M&A Deal Curaleaf Holdings, Inc. CURLF

Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.

Curaleaf Holdings, Inc. responded to Aurora Cannabis Inc.'s rejection of its enhanced acquisition proposal, challenging the Aurora Board's refusal to grant due diligence access. Curaleaf noted its offer represents an 86% premium to Aurora's unaffected 30-day VWAP and criticized Aurora for providing diligence access to other unnamed parties while obstructing Curaleaf's binding offer.

Counterparty
Aurora Cannabis Inc.
4:22 PM ET 8-K
Divestiture Cambium Networks Corp CMBMF

Cambium Networks Divestiture to Univastu UK Limited for $5.1M

Cambium Networks' subsidiary, Cambium Networks, Ltd (in administration), completed the sale of its remaining business and assets to Univastu UK Limited for approximately $5.1 million. The transaction includes the 'Cambium' brand name, intellectual property, and all shares in group subsidiaries across multiple countries, effectively disposing of the company's remaining product lines as a going concern.

Value
$5.1M
Counterparty
Univastu UK Limited
4:16 PM ET 8-K
M&A Deal Construction Partners, Inc. ROAD

Construction Partners M&A Deal with S.E. Cline Construction, Inc.

Construction Partners, Inc. (CPI) has completed the acquisition of S.E. Cline Construction, Inc., a commercial site development and underground utility construction company based in Palm Coast, Florida. The deal includes approximately 60 employees and a rail-served, permitted hot-mix asphalt plant site in Bunnell, Florida, which will be integrated into CPI's Florida platform, C.W. Roberts Contracting. This acquisition expands CPI's operations along the growing Interstate 95 corridor in northeast and central Florida.

Counterparty
S.E. Cline Construction, Inc.
4:10 PM ET 8-K
Clinical Trial Data SpyGlass Pharma, Inc. SGP

SpyGlass Pharma Clinical Trial Data

SpyGlass Pharma announced positive 4-year interim results from its first-in-human trial of the BIM-IOL System for glaucoma patients undergoing cataract surgery. The data showed a 37% reduction in mean intraocular pressure and 86% of patients remained off topical drops with no product-related adverse events reported.

Term
4 years
4:07 PM ET 8-K
M&A Deal CCO Holdings Capital Corp CHTR

CCO Holdings Capital M&A Deal with Cox Communications, Inc.

Charter Communications provided a status update regarding its completed transactions with Cox Communications. The company has posted a revised trending schedule to its investor relations website containing pro forma financial and operating information as if the deal had closed on January 1, 2024.

Counterparty
Cox Communications, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.